| Literature DB >> 33668721 |
Muhammad Saad Shaikh1, Mohid Abrar Lone2, Hesham Matabdin3, Muneeb Ahmed Lone4, Azeem Hussain Soomro5, Muhammad Sohail Zafar6,7.
Abstract
OBJECTIVE: The purpose of this study was to assess the clinical effectiveness of using a combination of enamel matrix protein derivative and acellular dermal matrix in comparison to acellular dermal matrix alone for treating gingival recessions.Entities:
Keywords: acellular dermal matrix; alveolar bone; enamel proteome; periodontal regeneration; systematic review
Year: 2021 PMID: 33668721 PMCID: PMC8005981 DOI: 10.3390/proteomes9010011
Source DB: PubMed Journal: Proteomes ISSN: 2227-7382
Figure 1Literature search strategy and screening criteria used.
Excluded studies after full-text analysis.
| Author/s | Reason for Exclusion |
|---|---|
| Saadoun [ | Case report |
| Wallace [ | No full-text available |
| de Oliveira et al. [ | Histologic and animal study |
Characteristics of the studies.
| Authors | Study Design | Treatment | Antibiotics | Follow-Up (Months) | |
|---|---|---|---|---|---|
| Test Group | Control Group | ||||
| Shin et al. | Single-center | EMD + ADM + CAF | ADM + CAF | Y | 3, 6 |
| Pourabbas et al. | Single-center | EMD + ADM + CAF | ADM + CAF | Y | 2, 4, 6 |
| Alves et al. | Single-center | EMD + ADM + CAF | ADM + CAF | Y | 6 |
| Costa et al. | Single-center | EMD + ADM + CAF | ADM + CAF | Y | 3, 6, 12 |
ADM (Acellular dermal matrix), CAF (Coronally advanced flap), EMD (Enamel matrix protein derivative), RCT (Randomized controlled clinical trial), Y (Yes).
Characteristics of participants and defects.
| Authors | Participant Characteristics | Defect Characteristics | |||||||
|---|---|---|---|---|---|---|---|---|---|
|
| Mean Age (Years) | Age Range (Years) | Gender (M/F) | Drop-Outs | Smoking | Number of Defects | Defect Type | Type of Tooth | |
| Shin et al. [ | 14 | 45.4 | 23–62 | 8/6 | 0 | In | 82 | Miller I to III | Non-molars |
| Pourabbas et al. [ | 15 | NR | 26–63 | 7/8 | 0 | Ex | 36 | Miller I and II | Non-molars |
| Alves et al. [ | 20 | NR | 30–50 | 7/12 | 1 | In | 38 | Miller I and II | Non-molars |
| Costa et al. [ | 19 | NR | 30–50 | NR | 0 | In | 38 | Miller I and II | Non-molars |
Ex (Excluded), In (Included), NR (Not reported).
Figure 2Bias risk graph: Individual risk of bias item shown as percentages across each included paper.
Figure 3Bias risk summary: Each risk of bias item for the included papers.
Effects of intervention and evaluation of various parameters.
| Authors | RC (%) | KTW Change (mm) | REC Change (mm) | CAL Change (mm) | PD Change (mm) |
|---|---|---|---|---|---|
| Shin et al. [ | T: 79.4 ± 16.0 | T: 0.89 ± 0.66 | T: 1.83 ± 0.58 | T: 1.86 ± 0.60 | T: 0.03 ± 0.08 |
| C: 73.4 ± 26.3 | C: 0.52 ± 0.56 | C: 1.76 ± 0.71 | C: 1.79 ± 0.70 | C: 0.07 ± 0.20 | |
| Pourabbas et al. [ | T: 84.90 ± 20.14 | T: 0.8 ± 1.45 | T: 2.11 ± 1.37 | T: 2.11 ± 0.95 | T: 0.02 ± 0.30 |
| C: 89.5 ± 18.54 | C: 1.03 ± 1.53 | C: 2.14 ± 1.42 | C: 2.12 ± 0.74 | C: -0.01 ± 0.30 | |
| Alves et al. [ | T: 55.4 ± 20.08 | T: 1.61 ± 1.30 | T: 1.94 ± 1.11 | T: 1.35 ± 0.99 | T: 0.31 ± 0.36 |
| C: 44 ± 20.6 | C: 1.55 ± 0.97 | C: 1.52 ± 0.76 | C: 1.07 ± 0.52 | C: 0.32 ± 0.29 | |
| Costa et al. [ | T: 59.7 ± 24.1 | T: 1.61 ± 1.13 | T: 2.17 ± 1.17 | T: 1.64 ± 1.28 | T: 0.49 ± 0.34 |
| C: 52.8 ± 17.0 | C: 1.63 ± 1.10 | C: 1.83 ± 0.76 | C: 1.43 ± 1.01 | C: 0.53 ± 0.43 |
C (Control group), CAL (Clinical attachment level), RC (Root coverage), KTW (Keratinized tissue width), PD (Probing depth), REC (Recession), T (Test group).
Figure 4Forest plots evaluating primary outcomes (A) RC, (B) Change in KTW and (C) REC reduction following surgical treatment using EMD + ADM and ADM alone (random effects; 95% CI; weighted mean difference).
Figure 5Forest plots evaluating secondary outcomes (A) CAL gain and (B) PD reduction following surgical treatment using EMD + ADM and ADM alone (random effects; 95% CI; weighted mean difference).